MannKind Corp. (MNKD)

[BuyFear_SellGreed]

AFREZZA $57 BILLION ANNUAL REVENUE... 382 Million Diabetics X 10% Capture X $1,500 Annual Afrezza Cost = $57 BILLION / YEAR. The numbers don't lie. The only question is whether we capture 10% of worldwide diabetics. I believe it will be done because Afrezza is targeting a new market of type 2 diabetics that should be on insulin but don't like needles. HUGE untapped market. Not to mention all existing insulin users converting over to Afrezza because it's the ONLY Ultra-Rapid Insulin that will be on the market in 2015. Also, Diabetes a World-wide growing Epidemic. It's estimated 400 Million Diabetics in 2015 and growing each year.